주요 내용으로 건너 뛰기
/ 자료 / 이벤트 / Model-Informed Drug Development: Current Landscape and Future Directions

Model-Informed Drug Development: Current Landscape and Future Directions

In-person Event | Cambridge, MA

Join us for an interactive event focused on Model-Informed Drug Development (MIDD). This event brings together drug development experts in Pharmacometrics, Quantitative Systems Pharmacology (QSP), Clinical Pharmacology, and Physiologically-Based Pharmacokinetic (PBPK) modeling to present the current MIDD landscape, regulatory initiatives, and trends. 

Following the presentations, we’ll open the floor for a Q&A session. We invite our audience to bring questions and ask our panel of experts anything—from basic concepts to the latest innovations.  

Example questions/topics for discussion: 

  • Have you seen examples where your model predictions are being validated in the clinic?
  • How can MIDD help with drug repurposing? 
  • How does MIDD support regulatory initiatives such as Project Optimus, reductions in animal studies, or Diversity Action Plans? 
  • How can MIDD help with novel modalities? 
  • How can MIDD support technology platforms? 

Don’t miss this chance to connect with experts and network with peers. 지금 등록! 

Agenda: 

  • 5:30-6:00pm – Registration 
  • 6:00-6:10pm – Introduction by Tong Zhu, PhD, VP, Global Head, Clinical Pharmacology and Translational Medicine
  • 6:10-6:20pm – PBPK presented by Hannah Jones, PhD, SVP, Simcyp PBPK Modeling Services
  • 6:20-6:30pm – QSP presented by Piet van der Graaf, PharmD, PhD, SVP, Head of QSP
  • 6:30-6:40pm – Pharmacometrics presented by Mirjam Trame, PharmD, PhD, VP, Certara Drug Development Solutions, Pharmacometrics Lead, US
  • 6:40-7:00pm – Q&A session
  • 7:00-8:00pm – Networking reception 

행사장:

CIC Cambridge – One Broadway, Cambridge, MA 02142

보내기
Powered by Translations.com GlobalLink Web Software